Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Molecular Assay Optimized for Meningitis Bacteria

By LabMedica International staff writers
Posted on 13 Feb 2011
An innovative technique enables the rapid detection of target nucleic acid sequences of Neisseria meningitidis under isothermal conditions without the need for complex instrumentation. More...


A loop-mediated isothermal amplification (LAMP) assay has been developed targeting a cell cycle transcription regulator gene (ctrA), for the rapid detection of capsular N. meningitidis with no cross-reactivity with other Neisseria species or with a comprehensive panel of other common human pathogens.

Scientists at the Royal Victoria Hospital (Belfast, UK), applied the LAMP assay to a total of 394 clinical specimens including samples from serum, ethylenediaminetetraacetic acid (EDTA) anticoagulated blood, throat swabs, cerebrospinal fluid , respiratory secretions, and fecal specimens. The majority of clinical specimens were obtained from pediatric patients who were younger than 13 years old.

An aliquot from each specimen type underwent total nucleic acid extraction, and the DNA extracts were subsequently analyzed in duplicate with a reference externally calibrated quantitative ctrA real-time polymerase chain reaction assay. This test determined meningococcal positivity status and the ctrA gene copy number present for each clinical specimen. The ctrA LAMP primers specifically amplified DNA from eight N. meningitidis-type reference strains. There was a high level of agreement between ctrA LAMP assay and real-time PCR assay with 36/394 positive for both assays and 355/394 negative for both assays.

The authors concluded that the LAMP assay was rapid and highly specific for the detection of all capsular N. meningitidis strains. The test demonstrated sensitivity for clinical specimens of 6 ctrA copies per reaction, which could be detected within 48 minutes and higher copy numbers could be detected in as little as 16 minutes.

The LAMP assay was simple to use and did not require specialized equipment, with positive specimens being readily identified by visual observation of color change or turbidity. This LAMP assay has the potential to be used for rapid detection of pathogenic meningococci in laboratories that do not have the instruments or expertise to perform real-time PCR. The study was published in February 2011 in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Royal Victoria Hospital




Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.